{"schema_version":"1","generated_at":"2026-11-10T19:40:22.504Z","data_as_of":null,"url":"https://www.findmykol.com/kol/racha-halawi","json_url":"https://www.findmykol.com/kol/racha-halawi/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"racha-halawi","name":"Racha Halawi","credential":"MD, MS","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"The University of Texas Southwestern Medical Center","institution_url":"https://www.findmykol.com/institution/ut-southwestern-medical-center","city":"Dallas","state":"TX","region":{"label":"South Central","url":"https://www.findmykol.com/region/south-central"}},"identifiers":{"npi":"1841587235","openalex":"A5067128861"},"summary":"Racha Halawi is an Oncology physician affiliated with The University of Texas Southwestern Medical Center. OpenAlex indexes 17 publications with 436 citations (h-index 10).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":17,"cited_by_count":436,"h_index":10,"latest_activity_year":2025,"source":"works"},"payments":{"company_count":41,"program_years":{"first":2021,"last":null},"rows_total":70,"shown":3,"withheld":67,"rows":[{"payer":"Novartis","program_year":2025,"amount_usd":5485.59,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1841587235"},{"payer":"ABBVIE INC.","program_year":2025,"amount_usd":33.24,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1841587235"},{"payer":"SOBI, INC","program_year":2025,"amount_usd":22.29,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1841587235"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1841587235","source":"payments"},"prescribing":{"data_year":2024,"areas_total":8,"areas_shown":3,"areas":[{"area":"Cancer & immunology","share_pct":49,"classes_total":6,"classes":[{"class":"PD-1 inhibitor","setting":"administered","share_pct":28.9,"drugs":[{"name":"Pembrolizumab","share_pct":100}],"max_beneficiaries":24},{"class":"Microtubule Inhibitor","setting":"administered","share_pct":18,"drugs":[{"name":"Paclitaxel","share_pct":100}],"max_beneficiaries":20}]},{"area":"Metabolism & gastrointestinal","share_pct":44.1,"classes_total":4,"classes":[{"class":"Other antiemetics","setting":"administered","share_pct":38.8,"drugs":[{"name":"Fosaprepitant","share_pct":100}],"max_beneficiaries":54},{"class":"Serotonin-3 Receptor Antagonist","setting":"administered","share_pct":4.8,"drugs":[{"name":"Palonosetron hcl","share_pct":69.4},{"name":"Granisetron hydrochloride","share_pct":30.6}],"max_beneficiaries":70}]},{"area":"Sensory organs","share_pct":4.6,"classes_total":1,"classes":[{"class":"Corticosteroid","setting":"administered","share_pct":4.6,"drugs":[{"name":"Dexamethasone sodium phosphate","share_pct":100}],"max_beneficiaries":89}]}],"care_setting":{"dominant":"office","data_year":2024,"office_pct":99.4,"facility_pct":0.6},"source":"medicare"},"publications":{"total":17,"shown":5,"withheld":12,"matched_by":"OpenAlex author record","recent":[{"title":"Growth factor use and rate of neutropenic complications in breast cancer patients treated with dose-dense paclitaxel: A 5-year experience from a safety net hospital.","year":2019,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2019.37.15_suppl.6527","status":"verified"},{"title":"Anemia in the elderly: a consequence of aging?","year":2017,"journal":"Expert Review of Hematology","source_url":"https://doi.org/10.1080/17474086.2017.1285695","status":"verified"},{"title":"Insights into the diagnosis and management of iron deficiency in inflammatory bowel disease","year":2017,"journal":"Expert Review of Hematology","source_url":"https://doi.org/10.1080/17474086.2017.1355233","status":"verified"},{"title":"A higher prevalence of hematologic malignancies in patients with thalassemia: Background and culprits","year":2017,"journal":"American Journal of Hematology","source_url":"https://doi.org/10.1002/ajh.24682","status":"verified"},{"title":"Hematologic malignancies in thalassemia: Adding new cases to the repertoire","year":2017,"journal":"American Journal of Hematology","source_url":"https://doi.org/10.1002/ajh.24681","status":"verified"}],"source":"works"},"contact":{"address_1":"3410 WORTH ST STE 400","city":"Dallas","state":"TX","zip":"752462092","phone":"142-370-1000","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1841587235","source":"identity"},"similar":[{"name":"Robert Toto","slug":"robert-toto","institution":"The University of Texas Southwestern Medical Center","specialty":"Nephrology","url":"https://www.findmykol.com/kol/robert-toto","json_url":"https://www.findmykol.com/kol/robert-toto/profile.json"},{"name":"Abhimanyu Garg","slug":"abhimanyu-garg","institution":"The University of Texas Southwestern Medical Center","specialty":"Endocrinology, Diabetes & Metabolism","url":"https://www.findmykol.com/kol/abhimanyu-garg","json_url":"https://www.findmykol.com/kol/abhimanyu-garg/profile.json"},{"name":"Graham Emslie","slug":"graham-emslie","institution":"The University of Texas Southwestern Medical Center","specialty":"Child & Adolescent Psychiatry","url":"https://www.findmykol.com/kol/graham-emslie","json_url":"https://www.findmykol.com/kol/graham-emslie/profile.json"},{"name":"Jing Chen","slug":"jing-chen","institution":"The University of Texas Southwestern Medical Center","specialty":"Nephrology","url":"https://www.findmykol.com/kol/jing-chen","json_url":"https://www.findmykol.com/kol/jing-chen/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Beth Karlan","slug":"beth-karlan","institution":"University of California, Los Angeles","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/beth-karlan","json_url":"https://www.findmykol.com/kol/beth-karlan/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":67,"publications":12}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2021-08-18","provider_certified":"2021-08-18","collected_at":"2026-11-06T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}